Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marcos J. G. De Lima"'
Autor:
Laura W. Dillon, Gege Gui, Kristin M. Page, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee, Scott L. Zeger, Firas El Chaer, Stephen Spellman, Alan Howard, Karen Chen, Jeffery Auletta, Steven M. Devine, Antonio Martin Jimenez Jimenez, Marcos J. G. De Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Daniel J. Weisdorf, Christopher S. Hourigan
Publikováno v:
JAMA. 329:745
ImportancePreventing relapse for adults with acute myeloid leukemia (AML) in first remission is the most common indication for allogeneic hematopoietic cell transplant. The presence of AML measurable residual disease (MRD) has been associated with hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45c8eae555957226898bbb45086aa8a6
https://doi.org/10.1001/jama.2023.1363
https://doi.org/10.1001/jama.2023.1363
Autor:
Omar H, Butt, Alice Y, Zhou, Paolo F, Caimi, Patrick H, Luckett, Julie K, Wisch, Paul-Robert, Derenoncourt, Kenneth, Lee, Gregory F, Wu, Marcos J G, de Lima, Jian L, Campian, Matthew J, Frank, John F, DiPersio, Armin, Ghobadi, Beau M, Ances
Publikováno v:
JAMA Oncology. 8:1652
ImportanceDetermining whether neurofilament light chain (NfL) elevations in patients who develop immune effector cell–associated neurotoxicity syndrome (ICANS) occur before or after infusion of cellular product is important to identify high-risk pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7399cee934c3d4ceebee7e778208d371
https://doi.org/10.1001/jamaoncol.2022.3738
https://doi.org/10.1001/jamaoncol.2022.3738